ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer
Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid
Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015
Sosei Subsidiary Heptares Announces Positive Outcome of Phase 1a Study with First-Ever Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients with Alzheimer's Disease
Advaxis's Cancer Immunotherapy Delays Progression of HER2+ Canine Osteosarcoma
Research and Markets: Global Cutaneous T-Cell Lymphoma Therapeutics Pipeline Review, H1 2015
Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
Three ways to separate long-term winners from stocks that fizzle.
Week ending April 27: Quarterly earnings continue to boost market's spirits.